Revvity (NYSE:RVTY) Upgraded to “Buy” at Wall Street Zen

Posted by Brenda Bartman on Aug 9th, 2026

Wall Street Zen upgraded shares of Revvity (NYSE:RVTY – Free Report) from a hold rating to a buy rating in a research report released on Saturday morning.

A number of other equities analysts have also weighed in on RVTY. Robert W. Baird set a $117.00 price objective on shares of Revvity in a research report on Wednesday, May 6th. TD Cowen restated a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th. Weiss Ratings raised shares of Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. Evercore reiterated an “outperform” rating on shares of Revvity in a report on Wednesday. Finally, Stifel Nicolaus reduced their price target on Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research note on Wednesday, May 6th. Three analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $108.36.

View Our Latest Stock Report on Revvity

Revvity Trading Up 0.5%

Revvity stock opened at $114.81 on Friday. The stock has a market cap of $12.81 billion, a PE ratio of 54.67, a P/E/G ratio of 2.09 and a beta of 1.07. The stock has a 50-day moving average price of $108.01 and a 200 day moving average price of $100.03. Revvity has a 52 week low of $81.22 and a 52 week high of $118.30. The company has a current ratio of 1.80, a quick ratio of 1.41 and a debt-to-equity ratio of 0.36.

Revvity (NYSE:RVTY – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The company had revenue of $711.00 million for the quarter, compared to analyst estimates of $702.96 million. During the same period in the prior year, the firm earned $1.18 EPS. The firm’s quarterly revenue was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Equities research analysts predict that Revvity will post 5.35 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is 13.33%.

Hedge Funds Weigh In On Revvity

Several hedge funds and other institutional investors have recently modified their holdings of the company. New Mexico Educational Retirement Board increased its position in Revvity by 1.9% during the 4th quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock worth $524,000 after purchasing an additional 100 shares in the last quarter. Allworth Financial LP raised its holdings in Revvity by 8.9% in the fourth quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock valued at $123,000 after buying an additional 104 shares during the period. EverSource Wealth Advisors LLC lifted its position in Revvity by 17.0% during the first quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock valued at $66,000 after buying an additional 109 shares in the last quarter. HighTower Advisors LLC lifted its position in Revvity by 2.6% during the fourth quarter. HighTower Advisors LLC now owns 5,141 shares of the company’s stock valued at $497,000 after buying an additional 129 shares in the last quarter. Finally, Cary Street Partners Financial LLC grew its stake in Revvity by 1.6% during the fourth quarter. Cary Street Partners Financial LLC now owns 8,941 shares of the company’s stock worth $865,000 after buying an additional 141 shares during the period. 86.65% of the stock is owned by institutional investors and hedge funds.

Revvity Company Profile

(Get Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.